Financial Information
- İntema
- Eczacıbaşı Pharmaceutical and Industrial Investment Co.
- Financial Information
- Announcements and Presentations
- Corporate Governance
- General Assembly
- Investor's Calendar
- Contact Us
- Eczacıbaşı Investment Holding Co.
- Financial Information
- Announcements and Presentations
- Corporate Governance
- General Assembly
- Investor's Calendar
- Contact Us
- Eczacıbaşı Group Annual Report
Financial Highlights
| SUMMARIZED FINANCIAL DATA (Thousand TL) | 2019/03 | 2018/03 | ||
| Revenue | 208,272 | 193,088 | ||
| Gross Profit | 76,019 | 74,822 | ||
| Operating Profit | 70,965 | 58,710 | ||
| Depreciation and Amortisation | 5,352 | 3,107 | ||
| EBITDA | 76,317 | 61,817 | ||
| Net Income / (Loss) | (8,550) | 51,570 | ||
| 2019/03 | 2018/12 | |||
| Total Assets | 4,565,812 | 4,456,472 | ||
| Total Shareholder's Equity | 3,989,351 | 3,997,844 | ||
| Total Current Assets | 1,053,623 | 912,383 | ||
| Total Current Liabilities | 347,544 | 241,737 | ||
| Capital Expenditures | 27,406 | 16,945 | ||
| Liquidity Ratios (%) | 2019/03 | 2018/03 | ||
| - Current Ratio | 3.03 | 3.21 | ||
| - Liquidity Ratio | 2.81 | 2.95 | ||
| The Ratios Related to Financial Structure (%) | 2019/03 | 2018/03 | ||
| - Total Liabilities / Total Assets | 0.13 | 0.10 | ||
| - Total Shareholders' Equity / Total Assets | 0.87 | 0.90 | ||
| - Total Shareholders' Equity / Total Liabilities | 6.92 | 8.81 | ||
| Profitability Ratios (%) | 2019/03 | 2018/03 | ||
| - Net Income (Loss) / Total Shareholders' Equity | 0.00 | 0.01 | ||
| - Net Income (Loss) / Total Assets | 0.00 | 0.01 | ||
| - Net Income (Loss) / Revenue | (0.04) | 0.27 | ||